Phreesia Retained Earnings (Accumulated Deficit) 2019-2025 | PHR

Phreesia retained earnings (accumulated deficit) from 2019 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Phreesia Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025 $-801
2024 $-743
2023 $-606
2022 $-430
2021 $-312
2020 $-284
2019 $-211
2018 $0
Phreesia Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025-04-30 $-805
2025-01-31 $-801
2024-10-31 $-795
2024-07-31 $-781
2024-04-30 $-763
2024-01-31 $-743
2023-10-31 $-712
2023-07-31 $-680
2023-04-30 $-644
2023-01-31 $-606
2022-10-31 $-568
2022-07-31 $-528
2022-04-30 $-481
2022-01-31 $-430
2021-10-31 $-383
2021-07-31 $-347
2021-04-30 $-323
2021-01-31 $-312
2020-10-31 $-304
2020-07-31 $-297
2020-04-30 $-291
2020-01-31 $-284
2019-10-31 $-281
2019-07-31 $-278
2019-04-30
2019-01-31
2018-10-31
2018-07-31
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.610B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.594B 60.55
Hims & Hers Health (HIMS) United States $12.830B 133.30
Doximity (DOCS) United States $11.392B 52.74
Tempus AI (TEM) United States $10.965B 0.00
IRhythm Technologies (IRTC) United States $4.223B 0.00
Inspire Medical Systems (INSP) United States $3.794B 59.28
Hinge Health (HNGE) United States $3.587B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.691B 0.00
Schrodinger (SDGR) United States $1.650B 0.00
Clover Health Investments (CLOV) United States $1.565B 0.00
Azenta (AZTA) United States $1.555B 72.25
Enovis (ENOV) United States $1.551B 8.65
Omnicell (OMCL) United States $1.318B 23.25
Evolent Health (EVH) United States $1.098B 93.50
Claritev (CTEV) United States $0.686B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Standard BioTools (LAB) United States $0.558B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Talkspace (TALK) United States $0.422B 126.00
TruBridge (TBRG) United States $0.349B 775.00
Outset Medical (OM) United States $0.312B 0.00
Health Catalyst (HCAT) United States $0.268B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.198B 0.00
Zepp Health (ZEPP) Netherlands $0.165B 0.00
KORU Medical Systems (KRMD) United States $0.162B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.106B 0.00
CareCloud (CCLD) United States $0.100B 3.82
Insight Molecular Diagnostics (IMDX) United States $0.085B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.022B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00